Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 832-845

  Zeltzer, Paul M ^a   Boyett, James M ^a   Finlay, Jonathan L ^a   Albright, A Leland ^a   Rorke, Lucy B ^a   Milstein, Jerrold M ^a   Allen, Jeffrey C ^a   Stevens, Kenneth R ^a   Stanley, Philip ^a   Li, Hao ^a   Wisoff, Jeffrey H ^a   Geyer, J Russell ^a   McGuire Cullen, Patsy ^a   Stehbens, James A ^a   Shurin, Susan B ^a   Packer, Roger J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; HYDROXYUREA; LOMUSTINE; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

AGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METASTASIS; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 0033050817     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.832     Document Type: Article

References (63)

1. Bailey P, Cushing H: Medulloblastoma cerebelli: A common type of midcerebellar glioma of childhood. Arch Neurol Psychiatr 14:192-224, 1925
2. Cushing H: Experiences with the cerebellar medulloblastoma: A critical review. Acta Pathol Microbiol Scand 7:1-86, 1930
3. Schaper A: Die fruhesten Differenzirugsvorgange im Centralnervensystem: Kritische Studie und Versuch einer Geschichte der Entwicklung nervoser Sustanz. Arch Entwicklungsmech Organ (Leipzig) 5:81-132, 1897
4. Hart MN, Earle KM: Primitive neuroectodermal tumors of the brain in children. Cancer 32:890-897, 1973
5. Rubinstein LJ: Commentary of the proposed revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56:1887-1888, 1985
6. Rorke LB, Gilles FH, Davis RL, et al: Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56:1869-1886, 1985
7. Hughes EN, Shillito J, Sallan SE, et al: Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984: The influence of radiation dose on the patterns of failure and survival. Cancer 61:1992-1998, 1988
8. Brand WN, Schneider PA, Tokars RP: Long-term results of a pilot study of low dose cranial-spinal irradiation for cerebellar medulloblastoma. Int J Radiat Oncol Biol Phys 13:1641-1645, 1987
9. Hershatter BW, Halperin EC, Cox EB: Medulloblastoma: The Duke University Medical Center Experience. Int J Radiat Oncol Biol Phys 12:1771-1777, 1986
10. Tomita T, McLone DG: Medulloblastoma in childhood: Results of radical resection and low-dose neuraxis radiation therapy. J Neurosurg 64:238-242, 1986
11. Evans AE, Jenkin RDT, Sposto R, et al: The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572-582, 1990
12. Tait DM, Thornton-Jones H, Bloom HJG, et al: Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464-469, 1990
13. Packer RJ, Sutton LN, Elterman R, et al: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, vincristine chemotherapy. J Neurosurg 81:690-698, 1994
14. Wara WM, Le QT, Sneed PK, et al: Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 30:551-556, 1994
15. Zerbini C, Gelber RD, Weinberg D, et al: Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 11:616-622, 1993
16. Loeffler JS, Kretschmar CS, Sallan ER, et al: Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma. Int J Radiat Oncol Biol Phys 15:177-181, 1988
17. Halperin EC, Friedman HS: Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis? Cancer 78:874-880, 1996
18. Cochrane DD, Gustavsson B, Poskitt KP, et al: The surgical and natural morbidity of aggressive resection for posterior fossa tumors in childhood. Pediatr Neurosurg 20:19-29, 1994
19. Bourne JP, Geyer R, Berger M, et al: The prognostic significance of postoperative residual contrast enhancement on CT scan in pediatric patients with medulloblastoma. J Neurooncol 14:263-270, 1992
20. Danjoux CE, Jenkin RD, McLaughlin J, et al: Childhood medulloblastoma in Ontario, 1977-1987: Population-based results. Med Pediatr Oncol: 26:1-9, 1996
21. Harisiadis L, Chang CH: Medulloblastoma in children: A correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys 2:833-841, 1977
22. Kellie SJ, Kovnar EH, Kun LE, et al: Neuraxis dissemination in pediatric brain tumors: Response to preirradiation chemotherapy. Cancer 69:1061-1066, 1992
23. Allen JC, Epstein F: Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS: The effect of age and the patients extent of disease on prognosis. J Neurosurg 57:446-451, 1982
24. Deutsch M, Thomas PRM, Krischer J, et al: Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2340 cGy/13) in patients with low-stage medulloblastoma: A combined Children's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg 24:167-177, 1996
25. Pendergrass TW, Milstein JM, Geyer JR, et al: Eight drugs in one day chemotherapy for brain tumors: Experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 5:1221-1231, 1987
26. Geyer JR, Zeltzer PM, Boyett JM, et al: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in one day: A report from the Children's Cancer Group. J Clin Oncol 12:1607-1615, 1994
27. Cohen BH, Zeltzer PM, Boyett JM, et al: Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: A Children's Cancer Group randomized trial. J Clin Oncol 13:1687-1696, 1995
28. Jakacki RI, Zeltzer PM, Boyett JM, et al: Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: A report of the Children's Cancer Group. J Clin Oncol 13:1377-1383, 1995
29. Jakacki RI, Luerssen T, Boyett J, et al: Impact of dural, subarachnoid and ventricular involvement on the outcome of localized (M-O) nonpineal supratentorial PNETS (SPNET): Results Of CCG-921. Eighth International Symposium on Pediatric Neuro-Oncology, May 6-9, 1998, Rome, Italy
30. Albright AL, Wisoff JH, Zeltzer PM, et al: Effects of medulloblastoma resections on outcome in children: A report from the Children's Cancer Group. Neurosurgery 38:265-271, 1996
31. Stevens KR, Cherlow J, Zeltzer PM, et al: The effect of pre-irradiation chemotherapy on the delivery of radiation therapy for medulloblastoma and supratentorial PNET: Results of the CCG #921 randomized protocol. Int J Radiat Oncol Biol Phys 27:133, 1993 (suppl 1)
32. Yao MS, Mehta MP, Boyett JM, et al: The effect of M-stage on patterns of failure in posterior fossa primitive neuro-ectodermal tumors treated on CCG-921: A phase III study in a high-risk patient population. Int J Radiat Oncol Biol Phys 38:469-476,1997
33. Cairncross JG, Pexman JH, Rathbone MP, et al: Analysis of post operative enhancement and other CT artifacts in brain tumor patients. J Neurooncol 2:273, 1984 (abstr)
34. Orton CG, Ellis F: A simplification in the use of the NSD concept in practical radiotherapy. Br J Radiol 46:529-537, 1973
35. Thatcher M, Glicksman AS: Field matching considerations in cerebrospinal irradiation. Int J Radiat Oncol Biol Phys 17:865-869, 1989
36. Van Dyk J, Jenkin RDT, Leung PMK, et al: Medulloblastoma treatment technique and radiation dosimetry. Int J Radiat Oncol Biol Phys 2:993-1005, 1977
37. Kaplan ES, Meier P: Non-parametric estimations from incomplete observations. J Am Stat Assoc 53:457-482, 1958
38. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trial requiring prolonged observation of each patient: 1. Introduction and design. Br J Cancer 34:585-612, 1976
39. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trial requiring prolonged observation of each patient: 2. Analysis and examples. Br J Cancer 35:1-39, 1977
40. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
41. Conover WJ: Practical Nonparametric Statistics (ed 2). New York, NY, Wiley, 1971, pp 216-227
42. Vietti TJ: Evaluation of toxicity: Clinical issues. Cancer Treat Rep 64:457-461, 1980
43. Madero L, Martin N, Contra T, et al: "Eight drugs in one day" chemotherapy administered before and after radiotherapy to children with brain tumors. Med Pediatr Oncol 25:305, 1995 (abstr)
44. Gianella-Borradori A, Zeltzer PM, Bodey B, et al. Choroid plexus tumors in childhood: Response to chemotherapy, and immuno-phenotypic profile using a panel of monoclonal antibodies. Cancer 69:809-816, 1992
45. Packer RJ, Sutton LN, Rorke LB, et al. Prognostic importance of cellular differentiation in medulloblastoma of childhood. J Neurosurg 61:296-301, 1984
46. Kramer S, Meadows AT, Pastore G, et al: Influence of place of treatment on diagnosis, treatment, and survival in three pediatric solid tumors. J Clin Oncol 2:917-923, 1984
47. Chang CH, Houseplan EM, Herbert C: An operative staging system for a megavoltage radiotherapeutic technique for cerebellar medulloblastomas. Radiology 93:1351-1359, 1969
48. Albright AL, Wisoff JH, Zeltzer PM, et al: Current neurosurgical treatment of medulloblastomas in children: A report from the Children's Cancer Study Group. Pediatr Neurosci 15:276-282, 1989
49. Caputy AJ, McCullough DC, Manz HJ, et al: A review of the factors influencing the prognosis of medulloblastoma: The importance of cell differentiation. J Neurosurg 66:80-87, 1987
50. Deutsch M: Radiotherapy for primary brain tumors in very young children. Cancer 50:2785-2789, 1982
51. Zeltzer PM: Chemotherapy for medulloblastoma: A review of treatment in recurrent and de novo tumors, in Zeltzer PM, Pochedly C (eds): Medulloblastomas in Children: New Concepts in Tumor Biology, Diagnosis and Treatment. New York, NY, Praeger Press, 1986, pp 182-199
52. Cohen ME, Duffner PK: Trends in treatment, referral patterns, and survival statistics of children with brain tumors in the United States, in Cohen ME, Duffner PK (eds): Brain Tumors in Children: Principles of Diagnosis and Treatment. New York, NY, Raven Press, 1984, pp 348-66
53. Laurent JP, Cheek WR: A new staging method versus TNM staging in children with posterior fossa primitive neuroectodermal tumor (medulloblastoma). Childs Nerv Syst 2:238-241, 1986
54. Ayan I, Kebudi R, Bayindir C, et al: Microscopic local leptomeningeal invasion at diagnosis of medulloblastoma. Int J Radiat Oncol Biol Phys 39:461-466, 1997
55. Healey EA, Barnes PD, Kupsky WJ, et al: The prognostic significance of postoperative residual tumor in ependymoma. Pediatr Neurosurg 16:57-65, 1990
56. Albright AL, Wisoff JH, Zeltzer P, et al: Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors: A neurosurgical perspective from the Children's Cancer Group. Pediatr Neurosurg 22:1-7, 1995
57. Griffin CA, Hawkins AL, Packer RJ, et al: Chromosome abnormalities in pediatric brain tumors. Cancer Res 48:175-180, 1988
58. Geyer JR, Patterson K, Boyett J. et al: Ploidy of primitive neuroectodermal tumors of the CNS (PNET) in infants treated with chemotherapy: Report from the Children's Cancer Group (CCG). Med Pediatr Oncol 25:268, 1995 (abstr)
59. Jereb B, Krishnaswamy S, Reid A, et al: Radiation for medulloblastoma adjusted to prevent recurrence to the cribriform plate region. Cancer 54:602-604, 1984
60. Jenkin D, Goddard K, Armstrong D, et al: Posterior fossa medulloblastoma in childhood: Treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 19:265-274, 1990
61. LeBaron S, Zeltzer PM, Zeltzer LK, et al: Assessment of quality of survival in children with medulloblastoma and cerebellar astrocytoma. Cancer 62:1215-1222, 1988
62. Duffner PK, Cohen ME, Voorhess ML, et al: Long-term effects of cranial irradiation on endocrine function in children with brain tumors: A prospective study. Cancer 56:2189-2193, 1985
63. Pasqualini T, Diez B, Domene H, et al: Long-term endocrine sequelae after surgery, radiotherapy, and chemotherapy in children with medulloblastoma. Cancer 59:801-806, 1987